Pharmacoepidemiologic research is our business

We provide pharmacoepidemiological research services for pharmaceutical companies, health care organizations and authorities. We study the actual use and effects of drugs in large numbers of people by utilizing population-wide health care registries. Our studies provide information on effectiveness, adverse effects and costs of drug treatment. Our methodology combines clinical, pharmacological, epidemiological and statistical knowledge.

Advantages for the customer

In our work we use reliable patient level information from existing national health registers. Studies performed by us do not require a massive study infrastructure because information accumulates in the data sources during normal health care procedures. Our process is fast, transparent, repeatable and traceable. This results in a cost-efficient way of evaluating the risk-benefit profiles of medical treatments.

For more information, please contact us

New article on polypharmacy and mortality in schizophrenia based on the Finnish healthcare register data (09.05.2012) - Read more

EPID Research on the road! (03.02.2012) - Read more

We have moved! (20.10.2011) - Read more

Meet us at the 5th Annual Clinical Forum on Oct 10-12, 2011 in Basel, Switzerland (26.09.2011) - Read more

First prize in a poster session at DIA's Euromeeting in Geneva, Switzerland (06.04.2011) - Read more

EPID Research joined the ENCePP® - a project lead by the EMA (18.1.2011) - Read more

Want to get started? Eager to try us out? The best way to move forward is to put us to a test: we can help you to identify and evaluate relevant data sources and make a proposal for a actual study. 

To learn more: 
email pasi.korhonen@epidresearch.com